Main Industry
Biotechnology
Main Product/Service
Utilizing genetic simulation technology and AI big data to perform simulated predictions of genetic and symptom likelihoods.
The content above was translated by Ai
Founded Year
2018
Unified Business No.
50861926
Status
Closed
Number of Employees
0
Total Paid-in
Capital
33,000,000 (NT$)
Location of Company
Taiwan
, Taichung City
Website
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Through the concept of precision medicine, treatment methods and the use of medication can be made more precise. Its main essence is to accurately understand the occurrence and progression of diseases. By effectively exploring the causes and effects of diseases, and combining medical scientific research with cross-disciplinary technologies, the prevention, diagnosis, and treatment of diseases can be made more precise.
The content above was translated by Ai
